Invention Grant
- Patent Title: Oxazolidin-2-one-pyrimidine derivatives and the use thereof as phosphatidylinositol-3-kinase inhibitors
-
Application No.: US15047574Application Date: 2016-02-18
-
Publication No.: US10202371B2Publication Date: 2019-02-12
- Inventor: Robin Alec Fairhurst , Pascal Furet , Frank Stephen Kalthoff , Andreas Lerchner , Heinrich Rueeger
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Laura K. Madden
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K45/06 ; C07D417/14 ; C07D413/14
Abstract:
The present invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as pharmaceutical compositions thereof, methods for their manufacture and uses for the treatment of conditions, diseases and disorders dependent on PI3K.
Public/Granted literature
- US20160168145A1 OXAZOLIDIN-2-ONE-PYRIMIDINE DERIVATIVES AND THE USE THEREOF AS PHOSPHATIDYLINOSITOL-3-KINASE INHIBITORS Public/Granted day:2016-06-16
Information query
IPC分类:
